Nature Medicine Retracts MS Paper With Ghost Data by Former GSK Researcher

Nearly 6 months after first expressing concern about the validity of a 2010 paper on multiple sclerosis, Nature Medicine has retracted the article for containing “erroneous” data—which in this case don’t seem to have existed, making them more fabricated than wrong. The paper, “Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease,” came from a group led by Jingwu Zhang, who at the time ran GlaxoSmithKline’s Research and Development Center in Shanghai.

 

Follow these links to Retraction Watch and Nature Medicine for more detailed information.